Transwell assays verified that the invasive ability of RPRD1B was blocked by SR11032 in RPRD1B-upregulated cells, and rescued by overexpressing c-Jun/c-Fos in RPRD1B-silenced GC cells (Supplementary Fig. 2D, E). Here, FOS is linked to gastric cancer.